Related Experiment Video
Updated: Nov 7, 2025
08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.9K
A medication adherence-enhancing simulation intervention in pediatric cystic fibrosis
Guy Van Schandevyl1, Georges Casimir2, Laurence Hanssens2
1Pediatric Cystic Fibrosis Center, 37469Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Summary
This study shows a new simulation intervention improves medication adherence in children with cystic fibrosis (CF). The engaging, hands-on approach helps pediatric CF patients understand and commit to their treatment plans.
Area of Science:
- Pediatric Pulmonology
- Medical Education
- Behavioral Science
Background:
- Adherence to chronic pulmonary medications in cystic fibrosis (CF) is a significant challenge, impacting treatment efficacy.
- Suboptimal adherence necessitates innovative strategies to improve patient engagement and outcomes in pediatric CF care.
Purpose of the Study:
- To assess the feasibility and effectiveness of a novel, multistep simulation intervention designed to enhance medication adherence in pediatric CF patients.
- To integrate motivational interviewing and educational components within a patient-centered approach.
Main Methods:
- A simulation intervention was developed and embedded within motivational interviewing and education sessions for pediatric CF patients (ages 7-13).
- Children actively participated in product simulation experiments to visualize the consequences of medication adherence versus non-adherence.
- An educational film summarized key concepts, and a patient-centered, empathic counseling style was employed.
Main Results:
- The intervention was found to be feasible and effective, with high satisfaction reported by parents regarding communication and motivation improvement.
- Pediatric patients demonstrated high engagement with the simulation experiments and showed improved understanding and association of knowledge with adherence, particularly for dornase alfa.
- Parents and children completed separate anonymous questionnaires two months post-intervention, providing valuable feedback on the program's impact.
Conclusions:
- Experiential, simulation-based learning is highly appropriate for enhancing medication adherence in pediatric CF.
- The multistep intervention is a feasible and effective strategy for improving adherence and patient understanding in this population.
Keywords:
Cystic fibrosisadherencechildclinical pharmacyeducationexperiential learningmotivational interviewingproduct simulationMore Related Videos
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
1.4K
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.3K
Related Concept Videos
01:24Cystic Fibrosis: Management
302
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
302
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.6K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.6K
01:28Drug Therapy
136
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
136
01:23Inhaled Medications
510
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
510
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
64
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
01:23Cystic Fibrosis: Pathogenesis
522
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
522